Fortis Hospital aims for an Earnings Before Interest, Taxes, Depreciation, and Amortisation (EBITDA) growth of about 20 per cent
'Every hospital now tracks length of stay closely. We cannot keep on increasing the critical care beds,' says Dr Bishnu Panigrahi, group head, medical strategy and operations, Fortis Healthcare
A well-known private healthcare group, Fortis on Friday inaugurated a state-of-the-art facility for the specialised treatment of blood cancers and disorders, which it said "represented a critical step" in addressing the urgent need for comprehensive holistic care. The Fortis Institute of Blood Disorders also integrates paediatric and geriatric care, advanced transplant procedures, and hematopathology expertise, all under one roof, Fortis Healthcare said in a release. The Institute also launched CAR-T cell therapy to its extensive network of Bone Marrow Transplant centres in Mohali, Delhi, Gurgaon, Noida, Mumbai and Bangalore, the statement said. This initiative is supported by a commercial collaboration with ImmunoACT, an IIT-Bombay spin-off and pioneer in India's first fully indigenous and commercially approved gene-modified cell therapy. The NexCAR19, India's first market-authorised CAR-T cell therapy, offers a new ray of hope for treating B-cell lymphomas and B-acute lymphoblast
Inorganic expansion gives instant market share in a new geography, greenfield works better in markets where a chain already has a presence, say industry players and analysts
n investigation was initiated by Sebi in the matter of Fortis Healthcare Ltd (FHL) after an article published in February 2018 said its promoters have taken at least Rs 500 crore out of FHL
State CM lays foundation of Phase-2 project of the hospital. Centre will construct facility on 50,000 sq ft at an estimated cost of Rs 25 cr
The hospital has chosen not to cut salaries of frontline health workers even as its looks to implement cost saving measures
Fortis has called for an extraordinary general meeting (EGM) on May 22 to vote on the resolution of removal of four Fortis board directors
Meanwhile, shares of Fortis soared 17.6 per cent on Friday amid reports that the Manipal Hospital, backed by TPG, was in advanced talks to merge itself with the company
Fortis is also exploring other structures for a capital infusion, which could result in dilution for existing shareholders, Singh said
The hospital has been barred from selling drugs and medicines on its premises
The girl was referred to the Fortis Memorial Research Institute, Gurgaon, as a case of dengue shock syndrome in a critical condition